Close

Ratings by Raymond James (Steven Seedhouse)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/16/2022 Intellia Therapeutics NTLA Maintain Outperform
(N/A)
 
 
  Details
8/30/2022 Jounce Therapeutics JNCE Maintain Strong Buy
(N/A)
 
 
  Details
8/12/2022 Landos Biopharma LABP Downgrade Market Perform
(Outperform)
1.23
(0.66)
-46.34% Details
8/12/2022 ProQR Therapeutics N.V. PRQR Upgrade Outperform
(Market Perform)
0.84
(0.74)
-11.9% Details
8/10/2022 Arcturus Therapeutics ARCT Downgrade Underperform
(Market Perform)
21.02
(13.05)
-37.92% Details
8/9/2022 VBI Vaccines VBIV Maintain Strong Buy
(N/A)
 
 
  Details
8/9/2022 Apellis Pharmaceuticals APLS Maintain Strong Buy
(N/A)
 
 
  Details
8/4/2022 ChemoCentryx CCXI Downgrade Market Perform
(Strong Buy)
24.11
(51.62)
114.1% Details
7/12/2022 Dyne Therapeutics DYN New Coverage Outperform
(N/A)
9.02
(13.38)
48.34% Details
7/12/2022 Avidity Biosciences RNA New Coverage Strong Buy
(N/A)
17.07
(18.75)
9.84% Details
5/18/2022 Galmed Pharmaceuticals GLMD Downgrade Market Perform
(Outperform)
0.58
(0.33)
-43.1% Details
5/13/2022 Landos Biopharma LABP Maintain Outperform
(N/A)
 
 
  Details
5/13/2022 Inflarx NV IFRX Maintain Strong Buy
(N/A)
 
 
  Details
5/9/2022 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
5/6/2022 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
5/6/2022 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
5/6/2022 Jounce Therapeutics JNCE Upgrade Strong Buy
(Outperform)
5.22
(2.73)
-47.7% Details
5/5/2022 Apellis Pharmaceuticals APLS Maintain Strong Buy
(N/A)
 
 
  Details
5/2/2022 Galmed Pharmaceuticals GLMD Maintain Outperform
(N/A)
 
 
  Details
3/31/2022 Inflarx NV IFRX Maintain Strong Buy
(N/A)
 
 
  Details
3/25/2022 Landos Biopharma LABP Maintain Outperform
(N/A)
 
 
  Details
3/10/2022 Mirum Pharamceuticals MIRM Maintain Strong Buy
(N/A)
 
 
  Details
3/8/2022 VBI Vaccines VBIV Maintain Strong Buy
(N/A)
 
 
  Details
3/1/2022 Apellis Pharmaceuticals APLS Maintain Strong Buy
(N/A)
 
 
  Details
2/11/2022 ProQR Therapeutics N.V. PRQR Downgrade Market Perform
(Strong Buy)
5.64
(0.74)
-86.88% Details
2/1/2022 ProQR Therapeutics N.V. PRQR New Coverage Strong Buy
(N/A)
5.20
(5.64)
8.46% Details
1/31/2022 Arcturus Therapeutics ARCT Upgrade Market Perform
(Underperform)
22.30
(13.05)
-41.48% Details
1/12/2022 Mirum Pharamceuticals MIRM Maintain Strong Buy
(N/A)
 
 
  Details
1/11/2022 Apellis Pharmaceuticals APLS Maintain Strong Buy
(N/A)
 
 
  Details
11/11/2021 CymaBay Therapeutic CBAY Maintain Strong Buy
(N/A)
 
 
  Details
11/9/2021 Apellis Pharmaceuticals APLS Maintain Strong Buy
(N/A)
 
 
  Details
11/5/2021 Inflarx NV IFRX Maintain Strong Buy
(N/A)
 
 
  Details
11/5/2021 NGM Biopharmaceuticals NGM Maintain Strong Buy
(N/A)
 
 
  Details
11/4/2021 Jounce Therapeutics JNCE Maintain Outperform
(N/A)
 
 
  Details
10/28/2021 Inflarx NV IFRX Upgrade Strong Buy
(Outperform)
2.86
(2.20)
-23.08% Details
10/8/2021 ChemoCentryx CCXI Upgrade Strong Buy
(Outperform)
19.60
(24.11)
23.01% Details
9/30/2021 Mirum Pharamceuticals MIRM Maintain Strong Buy
(N/A)
 
 
  Details
9/28/2021 ChemoCentryx CCXI Maintain Outperform
(N/A)
 
 
  Details
9/14/2021 Jounce Therapeutics JNCE Upgrade Outperform
(Market Perform)
6.35
(2.73)
-57.01% Details
9/13/2021 NGM Biopharmaceuticals NGM Upgrade Strong Buy
(Outperform)
21.25
(12.69)
-40.28% Details
9/8/2021 Kadmon Holdings KDMN Downgrade Market Perform
(Outperform)
5.30
(9.50)
79.25% Details
8/12/2021 Arcturus Therapeutics ARCT Downgrade Underperform
(Market Perform)
50.58
(22.30)
-55.91% Details
8/10/2021 Apellis Pharmaceuticals APLS Maintain Strong Buy
(N/A)
 
 
  Details
7/30/2021 Landos Biopharma LABP Maintain Outperform
(N/A)
 
 
  Details
6/29/2021 Intellia Therapeutics NTLA Maintain Outperform
(N/A)
 
 
  Details
6/7/2021 Biogen BIIB Upgrade Market Perform
(Underperform)
286.14
(234.72)
-17.97% Details
5/24/2021 NGM Biopharmaceuticals NGM Downgrade Outperform
(Strong Buy)
28.38
(21.25)
-25.12% Details
5/13/2021 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
5/7/2021 ChemoCentryx CCXI Downgrade Outperform
(Strong Buy)
27.49
(19.60)
-28.7% Details
5/7/2021 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
3/25/2021 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
3/5/2021 NGM Biopharmaceuticals NGM Maintain Strong Buy
(N/A)
 
 
  Details
3/5/2021 Kadmon Holdings KDMN Maintain Outperform
(N/A)
 
 
  Details
3/2/2021 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
3/1/2021 Landos Biopharma LABP New Coverage Outperform
(N/A)
12.99
(0.66)
-94.92% Details
2/26/2021 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
2/26/2021 Editas Medicine EDIT Maintain Market Perform
(N/A)
 
 
  Details
1/11/2021 Gilead Sciences GILD Maintain Market Perform
(N/A)
 
 
  Details
1/7/2021 Alexion Pharmaceuticals ALXN Downgrade Market Perform
(Outperform)
157.76
(182.01)
15.37% Details
1/7/2021 Editas Medicine EDIT Downgrade Market Perform
(Outperform)
80.54
(12.21)
-84.84% Details
12/29/2020 Arcturus Therapeutics ARCT Downgrade Market Perform
(Outperform)
98.13
(13.05)
-86.7% Details
11/13/2020 Mirum Pharamceuticals MIRM Maintain Strong Buy
(N/A)
 
 
  Details
11/10/2020 Arcturus Therapeutics ARCT Maintain Outperform
(N/A)
 
 
  Details
11/10/2020 Intercept Pharmaceuticals ICPT Upgrade Outperform
(Market Perform)
28.15
(15.58)
-44.65% Details
11/6/2020 Kadmon Holdings KDMN Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Editas Medicine EDIT Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 CymaBay Therapeutic CBAY Maintain Strong Buy
(N/A)
 
 
  Details
11/5/2020 Intellia Therapeutics NTLA Maintain Outperform
(N/A)
 
 
  Details
11/2/2020 Jounce Therapeutics JNCE Downgrade Market Perform
(Strong Buy)
8.32
(2.73)
-67.19% Details
10/29/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
10/27/2020 Apellis Pharmaceuticals APLS Maintain Strong Buy
(N/A)
 
 
  Details
10/19/2020 89bio Inc. ETNB New Coverage Strong Buy
(N/A)
23.73
(5.23)
-77.96% Details
9/9/2020 Mirum Pharamceuticals MIRM Maintain Strong Buy
(N/A)
 
 
  Details
8/27/2020 VBI Vaccines VBIV Upgrade Strong Buy
(Outperform)
3.28
(0.71)
-78.35% Details
8/11/2020 CymaBay Therapeutic CBAY Maintain Strong Buy
(N/A)
 
 
  Details
8/11/2020 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
8/11/2020 Arcturus Therapeutics ARCT Maintain Outperform
(N/A)
 
 
  Details
8/7/2020 Kadmon Holdings KDMN Maintain Outperform
(N/A)
 
 
  Details
8/7/2020 Editas Medicine EDIT Maintain Outperform
(N/A)
 
 
  Details
8/7/2020 Mirum Pharamceuticals MIRM Upgrade Strong Buy
(Outperform)
22.37
(21.40)
-4.34% Details
8/7/2020 Mimecast Limited MIME Upgrade Strong Buy
(Outperform)
45.97
(79.92)
73.85% Details
7/31/2020 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
7/31/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
7/24/2020 Arcturus Therapeutics ARCT Maintain Outperform
(N/A)
 
 
  Details
7/23/2020 CymaBay Therapeutic CBAY Upgrade Strong Buy
(Outperform)
3.51
(3.46)
-1.42% Details
7/22/2020 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
7/16/2020 Arcturus Therapeutics ARCT New Coverage Outperform
(N/A)
54.00
(13.05)
-75.83% Details
6/17/2020 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
5/22/2020 Intercept Pharmaceuticals ICPT Downgrade Outperform
(Strong Buy)
91.69
(15.58)
-83.01% Details
5/21/2020 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
5/21/2020 Kadmon Holdings KDMN Maintain Outperform
(N/A)
 
 
  Details
5/19/2020 Kadmon Holdings KDMN New Coverage Outperform
(N/A)
4.42
(5.30)
19.91% Details
5/18/2020 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
5/15/2020 Galmed Pharmaceuticals GLMD Maintain Outperform
(N/A)
 
 
  Details
5/14/2020 NGM Biopharmaceuticals NGM Maintain Strong Buy
(N/A)
 
 
  Details
5/12/2020 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
5/12/2020 CymaBay Therapeutic CBAY Upgrade Outperform
(Market Perform)
1.78
(3.51)
97.19% Details
5/8/2020 Mirum Pharamceuticals MIRM Maintain Outperform
(N/A)
 
 
  Details
5/1/2020 Gilead Sciences GILD Downgrade Market Perform
(Outperform)
83.14
(62.34)
-25.02% Details
4/30/2020 Inflarx NV IFRX Upgrade Outperform
(Market Perform)
5.80
(2.86)
-50.69% Details
4/29/2020 Gilead Sciences GILD Maintain Outperform
(N/A)
 
 
  Details
4/23/2020 Gilead Sciences GILD Maintain Outperform
(N/A)
 
 
  Details
4/17/2020 Gilead Sciences GILD Maintain Outperform
(N/A)
 
 
  Details
4/6/2020 NGM Biopharmaceuticals NGM New Coverage Strong Buy
(N/A)
12.45
(28.38)
127.95% Details
4/1/2020 Apellis Pharmaceuticals APLS New Coverage Strong Buy
(N/A)
28.68
(59.30)
106.76% Details
3/25/2020 Jounce Therapeutics JNCE Upgrade Strong Buy
(Outperform)
4.33
(8.32)
92.15% Details
3/13/2020 Mirum Pharamceuticals MIRM Maintain Outperform
(N/A)
 
 
  Details
3/13/2020 Bellicum Pharmaceuticals BLCM Maintain Outperform
(N/A)
 
 
  Details
3/11/2020 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
2/27/2020 Editas Medicine EDIT Maintain Outperform
(N/A)
 
 
  Details
2/5/2020 Gilead Sciences GILD Downgrade Outperform
(Strong Buy)
66.36
(62.34)
-6.06% Details
1/31/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
1/15/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
1/8/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
12/3/2019 Audentes Therapeutics BOLD Downgrade Market Perform
(Outperform)
28.61
(59.97)
109.61% Details
11/26/2019 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
11/26/2019 CymaBay Therapeutic CBAY Downgrade Market Perform
(Strong Buy)
5.55
(3.46)
-37.66% Details
11/14/2019 VBI Vaccines VBIV New Coverage Outperform
(N/A)
0.56
(3.28)
485.71% Details
11/1/2019 Intellia Therapeutics NTLA Upgrade Outperform
(Market Perform)
11.77
(54.20)
360.49% Details
10/25/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
10/21/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
8/30/2019 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
8/23/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
8/23/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
8/12/2019 Mirum Pharamceuticals MIRM New Coverage Outperform
(N/A)
14.77
(21.40)
44.89% Details
8/7/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
7/31/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
7/29/2019 Bellicum Pharmaceuticals BLCM New Coverage Outperform
(N/A)
1.47
(1.11)
-24.49% Details
7/29/2019 Audentes Therapeutics BOLD New Coverage Outperform
(N/A)
38.57
(28.61)
-25.82% Details
7/29/2019 Ra Pharma RARX Downgrade Market Perform
(Strong Buy)
35.96
(48.00)
33.48% Details
7/23/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
7/23/2019 Editas Medicine EDIT Maintain Outperform
(N/A)
 
 
  Details
6/26/2019 Biogen BIIB Maintain Market Perform
(N/A)
 
 
  Details
6/25/2019 Acer Therapeutics ACER Downgrade Market Perform
(Outperform)
19.28
(1.35)
-93% Details
6/12/2019 CymaBay Therapeutic CBAY Upgrade Strong Buy
(Outperform)
11.09
(3.46)
-68.8% Details
6/6/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
6/5/2019 Inflarx NV IFRX Downgrade Market Perform
(Outperform)
37.29
(2.20)
-94.1% Details
5/29/2019 CymaBay Therapeutic CBAY Maintain Outperform
(N/A)
 
 
  Details
5/24/2019 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
5/10/2019 Ra Pharma RARX Maintain Strong Buy
(N/A)
 
 
  Details
5/9/2019 CymaBay Therapeutic CBAY Maintain Outperform
(N/A)
 
 
  Details
5/7/2019 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
5/3/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
4/26/2019 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
4/23/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
4/23/2019 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
4/23/2019 CymaBay Therapeutic CBAY Maintain Outperform
(N/A)
 
 
  Details
4/10/2019 Ra Pharma RARX Maintain Outperform
(N/A)
 
 
  Details
4/10/2019 Alexion Pharmaceuticals ALXN New Coverage Outperform
(N/A)
139.75
(182.01)
30.24% Details
4/10/2019 Biogen BIIB New Coverage Market Perform
(N/A)
239.74
(329.01)
37.24% Details
3/8/2019 Ra Pharma RARX Maintain Strong Buy
(N/A)
 
 
  Details
2/28/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
2/15/2019 Acer Therapeutics ACER New Coverage Outperform
(N/A)
24.35
(19.28)
-20.82% Details
2/12/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
2/5/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
2/4/2019 Intercept Pharmaceuticals ICPT Upgrade Strong Buy
(Outperform)
116.62
(91.69)
-21.38% Details
1/24/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
10/2/2018 Intercept Pharmaceuticals ICPT Downgrade Outperform
(Strong Buy)
126.36
(116.62)
-7.71% Details